| Christine Panayotof, BSPT | |
|
22881 Sussex Hwy, Seaford, DE 19973-5851 | |
| (302) 600-1720 | |
| Not Available |
| Full Name | Christine Panayotof |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 22881 Sussex Hwy, Seaford, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336913870 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | J1-0014680 (Delaware) | Primary |
| Provider Name | Benchmark Physical Therapy Of Delaware Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1598222390 PECOS PAC ID: 4284964669 Enrollment ID: O20190927000706 |
News Archive
Automating volumetric titration in whole series of samples used to be a challenge: Firstly, risk of ambient moisture compromising sample integrity.
You've signed up for the gym membership. You've bought new workout clothes and shoes. You've made a promise to yourself to stick to your New Year's resolution to exercise and lose weight. You hit the gym, you work out hard for a week, then you wake up one morning and pain is shooting through your heel.
St. Jude Medical, Inc., a global medical device company, today announced results of the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) 10-Year Follow-up Study at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston. The study demonstrated implantable cardioverter defibrillator (ICD) therapy significantly reduces mortality for at least 11 years in patients with moderate heart failure (HF).
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
Cancer has been recently shown to be affected by protein clusters, particularly by the aggregation of mutant variants of the tumor suppressor protein p53, which are present in more than half of malignant tumors.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine Panayotof, BSPT 1200 Corporate Dr Ste 400, Hoover, AL 35242-5424 Ph: (423) 405-6356 | Christine Panayotof, BSPT 22881 Sussex Hwy, Seaford, DE 19973-5851 Ph: (302) 600-1720 |
News Archive
Automating volumetric titration in whole series of samples used to be a challenge: Firstly, risk of ambient moisture compromising sample integrity.
You've signed up for the gym membership. You've bought new workout clothes and shoes. You've made a promise to yourself to stick to your New Year's resolution to exercise and lose weight. You hit the gym, you work out hard for a week, then you wake up one morning and pain is shooting through your heel.
St. Jude Medical, Inc., a global medical device company, today announced results of the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) 10-Year Follow-up Study at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston. The study demonstrated implantable cardioverter defibrillator (ICD) therapy significantly reduces mortality for at least 11 years in patients with moderate heart failure (HF).
DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.
Cancer has been recently shown to be affected by protein clusters, particularly by the aggregation of mutant variants of the tumor suppressor protein p53, which are present in more than half of malignant tumors.
› Verified 6 days ago
Richard Sullivan, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 22830 & 22832 Sussex Highway, Suite 13 & 14, Seaford, DE 19973 Phone: 302-536-5562 Fax: 302-628-5313 | |
Ms. Hannah Rae Porter, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 808 Middleford Rd, Seaford, DE 19973 Phone: 302-629-4024 Fax: 302-629-6371 | |
Nicholas Elliot Galeone, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15 Fallon Ave, Seaford, DE 19973 Phone: 302-536-1774 Fax: 302-536-7096 | |
Clement Raymond Tajon, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 Middleford Rd, Seaford, DE 19973 Phone: 302-629-6611 | |
Ekta Sharma, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 715 King Street, Lofland Park Center, Seaford, DE 19973 Phone: 302-628-3000 | |
Mr. Percival Corpuz Jr., Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 715 E King St, Seaford, DE 19973 Phone: 610-925-4148 Fax: 610-347-4948 | |
Genevieve Luzano, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1310 Middleford Rd Ste 101, Seaford, DE 19973 Phone: 919-258-2714 Fax: 410-648-4878 |